Answers are grounded in this paper and cite their sources.
Hemoglobin H (Hb H) disease, caused by the functional loss in three of the four α-globin genes, exhibits substantial clinical heterogeneity that is not fully explained by primary α-globin genotypes. The genetic modifiers contributing to this phenotypic variability remain incompletely understood. Here, we present the largest whole-genome sequencing (WGS) study of Hb H disease to date, including 591 well-characterized patients and 1,246 ancestry matched controls from Southern China. Case-control GWAS identified two independent variants at the α-globin cluster, rs199594877 and rs34583256, with higher alternative allele frequencies in patients than in controls; rs199594877 was particularly enriched in patients with Hb Constant Spring (HCS). Case-only GWAS across 50 quantitative clinical traits identified six loci associated with hematological and iron metabolism phenotypes. At the HBS1L-MYB (HMIP) locus, rs11759553 was associated with increased Hb Bart's (γ4) levels (P = 3.66 × 10⁻¹⁴). In contrast to its beneficial effects in β-hemoglobinopathies, this association suggests that HMIP variation may have distinct biological consequences in Hb H disease. Together, these findings expand our understanding of the genetic architecture of phenotypic heterogeneity in Hb H disease and establish a comprehensive phenome-genome resource for α-thalassemia, providing candidate loci for further functional and clinical investigation.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: